Landry Y - Search Results

1

Peptidergic pathway in human skin and rat peritoneal mast cell activation.

Mousli M, Hugli TE, Landry Y, Bronner C. Mousli M, et al. Among authors: landry y. Immunopharmacology. 1994 Jan-Feb;27(1):1-11. doi: 10.1016/0162-3109(94)90002-7. Immunopharmacology. 1994. PMID: 7515863 Review.

2

Role of positive charges of neuropeptide Y fragments in mast cell activation.

Mousli M, Landry Y. Mousli M, et al. Among authors: landry y. Agents Actions. 1994 Jun;41 Spec No:C41-2. doi: 10.1007/BF02007758. Agents Actions. 1994. PMID: 7526655

3

Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli.

Emadi-Khiav B, Mousli M, Bronner C, Landry Y. Emadi-Khiav B, et al. Among authors: landry y. Eur J Pharmacol. 1995 Jan 5;272(1):97-102. doi: 10.1016/0014-2999(94)00628-k. Eur J Pharmacol. 1995. PMID: 7536161

4

Structural requirements for neuropeptide Y in mast cell and G protein activation.

Mousli M, Trifilieff A, Pelton JT, Gies JP, Landry Y. Mousli M, et al. Among authors: landry y. Eur J Pharmacol. 1995 Mar 15;289(1):125-33. doi: 10.1016/0922-4106(95)90177-9. Eur J Pharmacol. 1995. PMID: 7540143

5

The mechanism of inhibition of alkylamines on the mast-cell peptidergic pathway.

Fischer T, Bronner C, Landry Y, Mousli M. Fischer T, et al. Among authors: landry y. Biochim Biophys Acta. 1993 Apr 16;1176(3):305-12. doi: 10.1016/0167-4889(93)90059-x. Biochim Biophys Acta. 1993. PMID: 8471631

6

Role of G-proteins in peptidergic activation of both human and rat cutaneous mast cells.

Emadi-Khiav B, Mousli M, Landry Y. Emadi-Khiav B, et al. Among authors: landry y. Inflamm Res. 1995 Apr;44 Suppl 1:S26-7. doi: 10.1007/BF01674379. Inflamm Res. 1995. PMID: 8520984 No abstract available.

7

Mast cell activation involves plasma membrane potential- and thapsigargin-sensitive intracellular calcium pools.

Kassel O, Amrani Y, Landry Y, Bronner C. Kassel O, et al. Among authors: landry y. Fundam Clin Pharmacol. 1995;9(6):531-9. doi: 10.1111/j.1472-8206.1995.tb00530.x. Fundam Clin Pharmacol. 1995. PMID: 8808173

8

Substance P-related inhibitors of mast cell exocytosis act on G-proteins or on the cell surface.

Chahdi A, Mousli M, Landry Y. Chahdi A, et al. Among authors: landry y. Eur J Pharmacol. 1998 Jan 12;341(2-3):329-35. doi: 10.1016/s0014-2999(97)01480-5. Eur J Pharmacol. 1998. PMID: 9543256

9

Activation of rat peritoneal mast cells by substance P and mastoparan.

Mousli M, Bronner C, Bueb JL, Tschirhart E, Gies JP, Landry Y. Mousli M, et al. Among authors: landry y. J Pharmacol Exp Ther. 1989 Jul;250(1):329-35. J Pharmacol Exp Ther. 1989. PMID: 2473189

10

Resting plasma membrane potential of rat peritoneal mast cells is set predominantly by the sodium pump.

Bronner C, Mousli M, Eleno N, Landry Y. Bronner C, et al. Among authors: landry y. FEBS Lett. 1989 Sep 25;255(2):401-4. doi: 10.1016/0014-5793(89)81132-9. FEBS Lett. 1989. PMID: 2477283 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters